Trial
NCT04371926
Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk
UnknownWITHDRAWNSAFETYConfidence: MEDIUM
Sponsor
Texas Cardiac Arrhythmia Research Foundation
Collaborators
—
Condition
COVID-19
Intervention
Hydroxychloroquine Sulfate
Why stopped
Concerned about the adverse effects of HCQ
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-06-04